The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: Redrow falls despite rise in profits

Tue, 09th Feb 2016 14:47

(ShareCast News) - The FTSE 250 continued to slide on Tuesday, with the second tier market down 140.79 points (0.91%) to 15,357.20 by mid-afternoon.Redrow was near the top of the fallers list despite posting a rise in first half pre-tax profit as revenue and completions grew.In the six months to the end of December, pre-tax profit increased 14% to a record £104m, on revenue of £603m, up 8% from the same period in 2015. Earnings per share, meanwhile, were 15% higher at 22.9p and the operating margin was 18.2% versus 17% the previous year. Legal completions were up 18% in the period to 2,178, with Help to Buy continuing to support demand. In addition, the company announced an interim dividend of 4p per share, which was double that of last year, and guidance of 10p for the year, compared to 6p in 2015.Chairman Steve Morgan said: "We are only at the beginning of the spring selling season, however demand for new homes remains robust. We ended the first half with a record order book up 51% on this time last year, and in the first six weeks of the second half have secured 455 private reservations, 10% ahead of last year." However the company did confirm it has seen a slowdown in London despite the rest of the UK performing well.Sophos Group's third quarter results were hit by the strong dollar depleting some of its gains made through a major acquisition in the three months to 31 December 2015.Like-for-like billings were up 17.4% year-on-year, with growth across all major regions and product categories, though notwithstanding stronger quarterly comparatives. Sophos' reported billings grew 10.6% year-on-year, reflecting significant currency headwinds including the devaluation of both sterling and the euro against the US dollar. Reported revenue in the quarter was $121.4m (£84.16m), up 4.7% over 12 months earlier, or 11.9% growth on a constant currency basis. Its reported cash EBITDA was $34.8m, up 5.5% year-on-year or 16.3% at constant currency.Investors also weren't convinced with Allied Minds saying that 2015 was a year of investment rather than cashflow, as it updated the market of its trading in the 12 months to 31 December 2015.The company had net cash and investments - including cash in the form of fixed income securities - of $194.8m (£135.37m) at the end of the year, down from $261.5m at the end of 2014. Revenues fell during the year to $3.2m, from $7.7m, with the board blaming revenue shortfall at RF Biocidics, with following initial regulatory approval now required certification for each individual installation, delaying revenue.During 2015, the firm invested $102.8m into new and existing portfolio companies, including leading fundraisings of $63.6m - with $42.2m coming from third-party investment - to accelerate the development of two of the group's existing companies.Meanwhile Poundland continued to rise on Tuesday, a day after Deutsche Bank upgraded the company from 'hold' to 'buy' - a move it said was controversial.It said the company has had a challenging start to the year, but believed the company can help itself to offset the challenges it faces. It also noted consensus earnings for the year to the end of March have fallen by 40%, due to weak sales and the 99p Stores business."We have little expectation that like for like sales trends will improve in the near-term, so operational deleverage risks remain." However, Deutsche Bank did see two years of "exceptionally strong" earnings growth, and believed positive catalysts from the company's multi-price trials in the UK could alleviate concerns about the business model.FTSE 250 - RisersAcacia Mining (ACA) 237.00p 3.31%QinetiQ Group (QQ.) 218.80p 3.21%Aveva Group (AVV) 1,263.00p 2.10%IG Group Holdings (IGG) 711.00p 1.72%Cineworld Group (CINE) 463.40p 1.40%Daejan Holdings (DJAN) 5,815.00p 1.13%Ultra Electronics Holdings (ULE) 1,794.00p 1.07%Poundland Group (PLND) 148.10p 0.95%Kier Group (KIE) 1,227.00p 0.90%B&M European Value Retail S.A. (DI) (BME) 276.00p 0.88%FTSE 250 - FallersVedanta Resources (VED) 217.80p -10.74%Redrow (RDW) 381.60p -9.57%Sophos Group (SOPH) 187.40p -9.12%Enterprise Inns (ETI) 71.85p -9.05%OneSavings Bank (OSB) 264.70p -7.99%Aldermore Group (ALD) 180.00p -7.07%Shawbrook Group (SHAW) 261.60p -6.77%Allied Minds (ALM) 279.00p -6.47%Virgin Money Holdings (UK) (VM.) 270.30p -6.34%Vectura Group (VEC) 168.00p -5.88%
More News
25 Apr 2016 11:00

LONDON MARKET MIDDAY: Resource Stocks Drag FTSE As Brent Rally Stalls

Read more
25 Apr 2016 10:18

EXTRA: Allied Minds Annual Loss Widens As It Invests In New Businesses

Read more
25 Apr 2016 09:38

WINNERS & LOSERS SUMMARY: St Ives Dives After Profit Warning

Read more
25 Apr 2016 07:36

LONDON MARKET OPEN: Mixed Trade As Miners And Drillers Drag FTSE 100

Read more
25 Apr 2016 07:19

Allied Minds losses widen as group ramps up invesment

(ShareCast News) - Science and technology development company Allied Minds reported a wider loss in 2015 in its annual report on Monday, which it blamed on an increase in its investment in research and development and the creation of four new businesses during the year. The FTSE 250 firm posted a ne

Read more
25 Apr 2016 06:25

TOP NEWS: Allied Minds Loss Widens As It Invests In New Businesses

Read more
18 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
16 Mar 2016 08:36

LONDON MARKET OPEN: Commodity Stocks Take Back Losses But Hikma Falls

Read more
16 Mar 2016 08:08

Allied Minds forms cancer drug arm with NYU School of Medicine

(ShareCast News) - Allied Minds has launched a new subsidiary to develop potential cancer drugs from compounds developed by the New York University School of Medicine. Allied's joint venture with pharma group Bristol-Myers Squibb, Allied-Bristol Life Sciences, has set up the subsidiary, called ißeCa

Read more
16 Mar 2016 07:36

Allied Minds Joint Venture Signs Deal With New York University

Read more
9 Feb 2016 10:42

WINNERS & LOSERS SUMMARY: Bond Disclosure Sends Legal & General Higher

Read more
9 Feb 2016 09:08

UPDATE: Allied Minds Hit By Revenue Drop From RF Biocidics Shortfall

Read more
9 Feb 2016 07:59

Allied Minds Eyes Commercialisation Opportunities In 2016

Read more
9 Feb 2016 07:32

Allied Minds marks 2015 as year of investment

(ShareCast News) - Allied Minds laid out 2015 as a year of investment, rather than cashflow, as it updated the market on Tuesday of its trading in the 12 months to 31 December 2015. The company had net cash and investments - including cash in the form of fixed income securities - of $194.8m (£135.37

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.